Micron Technology, Inc. vs Health Care Select Sector SPDR Fund — how do they compare? Micron Technology, Inc. trades at $1,029 (market cap $1.17T), while Health Care Select Sector SPDR Fund trades at $170.81 (market cap $43.48B). The key difference: Micron Technology, Inc. is far larger — about 26.9× Health Care Select Sector SPDR Fund's market cap, and Micron Technology, Inc. pays a 0.06% dividend while Health Care Select Sector SPDR Fund pays none. Which is the better fit depends on your goals — on Pluang, investors hold Micron Technology, Inc. for 48 Days and Health Care Select Sector SPDR Fund for 100 Days on average.
| MU | XLV | |
|---|---|---|
Market Cap | $1.17T | $43.48B |
Volume | 29,425,906 | 11,121,431 |
Sector | Technology | — |
52-Week High | $1.21K | $175.68 |
52-Week Low | $181.60 | $141.95 |
Typical Hold Time | 48 Days | 100 Days |
Enterprise Value | $1.13T | — |
Dividend Yield | 0.06% | — |
Signals from Pluang's Aura AI — not financial advice
Micron Technology (MU) trades at $1,035.84, down 4.79% on the day but maintains strong technical momentum with a bullish moving average signal. The company demonstrates exceptional fundamental strength with 63.8% net income margin and 91.77% ROE, supported by three consecutive quarterly earnings beats. Recent strategic customer agreements covering 35% of revenue through 2030 provide visibility into sustained AI-driven memory demand growth.
Outlook remains positive with analyst consensus target of $1,590 representing 53% upside potential. Key opportunities include AI memory market expansion and supply constraints through 2028, while risks center on cyclical industry dynamics and potential growth deceleration. The stock's current valuation at 13.94 P/E appears reasonable given growth trajectory.
XLV trades at $168.16, down 0.39% with a bearish technical signal from moving averages. The healthcare ETF maintains strong cost advantages with a 0.08% expense ratio compared to peers. Recent news highlights XLV's defensive positioning during market volatility and its historical outperformance during Fed rate hikes. Technical indicators show RSI levels in neutral territory while ADX signals selling pressure.
XLV offers diversified healthcare exposure with competitive expense ratios, positioning it well for defensive investing. Key risks include political uncertainty around healthcare policy and concentrated exposure to domestic S&P 500 stocks. The ETF's low-cost structure and sector diversification provide stability amid market volatility, though technical indicators suggest near-term caution.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Micron historically focused on designing and manufacturing DRAM for PCs. The firm then expanded into the NAND flash memory market. It increased its DRAM scale with the purchase of Elpida (completed in mid-2013) and Inotera (completed in December 2016). The firm's DRAM and NAND products tailored to PCs, data centers, smartphones, game consoles, automotives, and other computing devices.
Read more on MU →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →